These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1974458)

  • 1. Peptide models of dynorphin A(1-17) incorporating minimally homologous substitutes for the potential amphiphilic beta strand in residues 7-15.
    Taylor JW
    Biochemistry; 1990 Jun; 29(22):5364-73. PubMed ID: 1974458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton NMR and CD solution conformation determination and opioid receptor binding studies of a dynorphin A(1-17) model peptide.
    Vaughn JB; Taylor JW
    Biochim Biophys Acta; 1989 Nov; 999(2):135-46. PubMed ID: 2574597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irreversible blockade of the kappa-receptor by a newly synthesized dynorphin derivative containing a 3-nitro-2-pyridinesulfenyl group.
    Koike K; Takayanagi I; Hirakura Y; Matsueda R
    Arch Int Pharmacodyn Ther; 1991; 313():33-46. PubMed ID: 1687773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynorphin A-(1-13)-Tyr14-Leu15-Phe16-Asn17-Gly18-Pro19 : a potent and selective kappa opioid peptide.
    Martinka GP; Jhamandas K; Sabourin L; Lapierre C; Lemaire S
    Eur J Pharmacol; 1991 Apr; 196(2):161-7. PubMed ID: 1678718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and physical properties of a beta-endorphin analog containing only D-amino acids in the amphiphilic helical segment 13-31.
    Blanc JP; Kaiser ET
    J Biol Chem; 1984 Aug; 259(15):9549-56. PubMed ID: 6086639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-endorphin. Biological activity of analogs containing dermorphin and dynorphin sequences: ileum and vas deferens assays.
    Ho CL; Li CH
    Int J Pept Protein Res; 1987 Jan; 29(1):134-9. PubMed ID: 2883148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
    Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
    Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [2',6'-Dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group: potent and selective kappa opioid antagonists.
    Lu Y; Nguyen TM; Weltrowska G; Berezowska I; Lemieux C; Chung NN; Schiller PW
    J Med Chem; 2001 Sep; 44(19):3048-53. PubMed ID: 11543672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency.
    Lung FD; Meyer JP; Lou BS; Xiang L; Li G; Davis P; DeLeon IA; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Jun; 39(13):2456-60. PubMed ID: 8691442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of the requirement for an amphiphilic helical structure in beta-endorphin through the design, synthesis, and study of model peptides.
    Blanc JP; Taylor JW; Miller RJ; Kaiser ET
    J Biol Chem; 1983 Jul; 258(13):8277-84. PubMed ID: 6305980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N,N-diallyl-tyrosyl substitution confers antagonist properties on the kappa-selective opioid peptide [D-Pro10]dynorphin A(1-11).
    Gairin JE; Mazarguil H; Alvinerie P; Botanch C; Cros J; Meunier JC
    Br J Pharmacol; 1988 Dec; 95(4):1023-30. PubMed ID: 2905908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The choice of opioid receptor subtype in isolated preparations by dynorphins.
    Oka T; Aoki K; Kajiwara M
    Life Sci; 1983; 33 Suppl 1():311-4. PubMed ID: 6141492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of analogs of dynorphin-A(1-13) substituted in positions 2 and 4: design of [Ala2,Trp4]-Dyn-A(1-13) as a putative selective opioid antagonist.
    Lemaire S; Turcotte A
    Can J Physiol Pharmacol; 1986 Jun; 64(6):673-8. PubMed ID: 2875777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel opioid peptide, leumorphin, acts as an agonist at the kappa opiate receptor.
    Suda M; Nakao K; Yoshimasa T; Ikeda Y; Sakamoto M; Yanaihara N; Numa S; Imura H
    Life Sci; 1983 Jun; 32(24):2769-75. PubMed ID: 6134225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
    Cox BM; Chavkin C
    Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144
    [No Abstract]   [Full Text] [Related]  

  • 16. Opioid receptor selectivity of peptide models of beta-endorphin.
    Taylor JW; Kaiser ET
    Int J Pept Protein Res; 1989 Jul; 34(1):75-80. PubMed ID: 2551833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 1. Conformational constraint in the "message" sequence.
    Arttamangkul S; Murray TF; DeLander GE; Aldrich JV
    J Med Chem; 1995 Jun; 38(13):2410-7. PubMed ID: 7608905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynorphin A(1-8): stability and implications for in vitro opioid activity.
    Bell KM; Traynor JR
    Can J Physiol Pharmacol; 1998 Mar; 76(3):325-33. PubMed ID: 9673796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
    Lung FD; Collins N; Stropova D; Davis P; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Mar; 39(5):1136-41. PubMed ID: 8676350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.